Pharmacists Provide Telemedicine in Addition to Clinic Visits to Improve Diabetes Management

Not Applicable

Completed

• Conditions: Telemedicine
• Interventions: Other: Telemedicine

• Registration Number: NCT02344082
• Lead Sponsor: Johns Hopkins University

Brief Summary

This prospective study will include both an intervention and control arm. The control arm will receive face-to-face pharmacy clinic visits per standard of care. The intervention arm will receive pharmacy clinic visits plus additional telephone follow-up. Patients with a hemoglobin A1c in the last 3 months greater than 9% will be eligible. Eligible patients must have a primary care physician at Johns Hopkins Outpatient Center (JHOC) or East Baltimore Medical Center (EBMC).

Purpose: To compare the change in hemoglobin A1c over the 3 month study period in the intervention group in which patients participate in telemedicine, to a control group in which they do not

Detailed Description

Not available

Study Timeline

• Study Start: 2015-01
• Study First Submitted: 2015-01-08
• Study First Submitted QC: 2015-01-21
• Study First Posted: 2015-01-22
• Primary Completion: 2015-06
• Study Completion: 2015-06
• Status Verified: 2018-12
• Last Update Submitted: 2018-12-18
• Last Update Posted: 2018-12-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Adult patients with a primary care provider at JHOC or EMBC
• Patients have seen primary care provider within last 6 months
• Patients with hemoglobin A1c greater than 9%

Exclusion Criteria

• Patients <18 years of age
• Patients with previously established care with JHH ambulatory care pharmacist
• Patients with communication barriers who do not have a caregiver
• Patients with new diagnosis of diabetes
• Patients who are pregnant or planning to become pregnant during the time of the study
• Patients followed by Endocrinology or Diabetes Center

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intervention Arm	Telemedicine	The intervention arm will receive pharmacy clinic visits plus additional telephone follow-up.

Primary Outcome Measures

Name	Time	Method
Change in hemoglobin A1c	3 months	A1c at 3 months - A1c at Baseline

Secondary Outcome Measures

Name	Time	Method
Pharmacist interventions (Number of pharmacist interventions (lifestyle or medication changes) made)	3 months	Number of pharmacist interventions (lifestyle or medication changes) made
Telemedicine Adherence (Percent of telephone encounters completed in intervention arm)	3 months	Percent of telephone encounters completed in intervention arm
Patient satisfaction (Based on survey results)	3 months	Based on survey results at final pharmacy clinic visit
Patient adherence to office visits (# visits attended/# of visits scheduled)	3 months	# visits attended/# of visits scheduled
Telemedicine in Usual Care (Percent of patients who receive telephone call under usual care)	3 months	Percent of patients who receive telephone call under usual care